Masaru Matsuda Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Masaru Matsuda.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Masaru Matsuda. Masaru Matsuda is SVP, General Counsel in HALOZYME THERAPEUTICS, INC. ($GYHT).

Masaru Matsuda in HALOZYME THERAPEUTICS, INC.

Trading Symbol: GYHT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Masaru Matsuda: SVP, General Counsel
Holdings: 17,699 shares
Latest Transaction: Feb 17 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Masaru Matsuda in HALOZYME THERAPEUTICS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 17 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA0.0013,544013,544
Feb 17 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA49.8423,3111,161,82023,311
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.004,12908,258
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.006,257018,769
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF49.842,047102,02216,57818.6 K to 16.6 K (-10.99 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.004,129018,62514.5 K to 18.6 K (+28.48 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF50.603,203162,07214,49617.7 K to 14.5 K (-18.10 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.006,257017,69911.4 K to 17.7 K (+54.68 %)
Sep 04 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.006,884013,766
Sep 04 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF27.702,38065,92611,44213.8 K to 11.4 K (-17.22 %)
Sep 04 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.006,884013,8226.9 K to 13.8 K (+99.22 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.004,130012,387
Feb 13 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF20.001,68133,6206,9388.6 K to 6.9 K (-19.50 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.004,13008,6194.5 K to 8.6 K (+92.00 %)
Feb 12 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA0.0025,026025,026
Feb 12 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA19.9853,2111,063,15653,211

Page:   1